Investment Stage: Series C
Portfolio 11
| Date | Name | Website | Total Raised | Location |
| 28.03.2017 | Antiva Bio... | antivabio.com | $137M | United Sta... |
| - | Precision ... | precisionbiosciences.com | $143.1M | United Sta... |
| - | Vero Biote... | vero-biotech.com | $145M | United Sta... |
| - | F2G | f2g.com | $291M | United Kin... |
| - | Turnstone ... | turnstonebio.com | $132.7M | United Sta... |
| - | ReViral | reviral.co.uk | $99M | United Kin... |
| - | Gliknik | gliknik.com | $124.4M | United Sta... |
| - | Zymeworks | zymeworks.com | $514.6M | Canada, Br... |
| - | AVROBIO | avrobio.com | $85M | United Sta... |
| - | Avidity Bi... | aviditybiosciences.com | $301M | United Sta... |
Show more
Mentions in press and media 4
| Date | Title | Description |
| 28.03.2017 | Brace Pharma Capital Leads $22M Series C for Antiva Biosciences | Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection, has raised a $22 million Series C financing led by Brace Phar... |
| 18.11.2015 | Therabron gets $6.75M for drug that helps premature babies breathe easy | The company’s lead compound, CG100, is based on recombinant human CC10 secretoglobins – proteins meant to restore the natural immune balance in the lungs of patients. These CC10 proteins are in low supply among premature infants, who haven’... |
| 19.06.2014 | Tyrogenex Receives $15M in Series D Financing | Tyrogenex Inc., a West Palm Beach, FL-based Xcovery Group company focused on discovering and developing novel patented cancer and ophthalmic therapeutics, received $15m in Series D financing. The backer was Brace Pharma, the U.S. investment... |
| - | Therabron gets $6.75M for drug that helps premature babies breathe easy | It’s quite common for premature infants to have difficulty breathing – in fact, it’s a leading cause of morbidity in babies born preterm. Maryland startup Therabron Therapeutics is developing a series of pediatric respiratory drugs, with a ... |